ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Biomark Diagnostics Inc (PK)

Biomark Diagnostics Inc (PK) (BMKDF)

0.1515
0.00
(0.00%)
Closed December 12 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.1515
Bid
0.0945
Ask
0.176
Volume
-
0.00 Day's Range 0.00
0.12476 52 Week Range 0.2303
Market Cap
Previous Close
0.1515
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
16,294
Shares Outstanding
90,886,229
Dividend Yield
-
PE Ratio
-9.55
Earnings Per Share (EPS)
-0.02
Revenue
163k
Net Profit
-1.43M

About Biomark Diagnostics Inc (PK)

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Richmond, British Columbia, Can
Founded
-
Biomark Diagnostics Inc (PK) is listed in the Medical Laboratories sector of the OTCMarkets with ticker BMKDF. The last closing price for Biomark Diagnostics (PK) was $0.15. Over the last year, Biomark Diagnostics (PK) shares have traded in a share price range of $ 0.12476 to $ 0.2303.

Biomark Diagnostics (PK) currently has 90,886,229 shares outstanding. The market capitalization of Biomark Diagnostics (PK) is $13.77 million. Biomark Diagnostics (PK) has a price to earnings ratio (PE ratio) of -9.55.

BMKDF Latest News

New Cancer Diagnostic Primed to Change the Industry

New Cancer Diagnostic Primed to Change the Industry PR Newswire NEW YORK and VANCOUVER, British Columbia, March 5, 2015 NEW YORK and VANCOUVER, British Columbia, March 5, 2015 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.15150.15150.15153000.1515CS
4-0.0085-5.31250.160.16750.12476281830.1557262CS
12-0.0685-31.13636363640.220.220.12476162940.17343632CS
26-0.0324-17.61827079930.18390.22060.12476122860.17514231CS
52-0.03975-20.78431372550.191250.23030.12476121020.19559158CS
156-0.0818-35.0621517360.23330.2530620.118121220.18254134CS
260-0.0485-24.250.20.50830.0824155180.23823211CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UNDRUnderSea Recovery Corporation (CE)
$ 0.001
(99,900.00%)
50k
KLMRKLM Royal Dutch Airlines (CE)
$ 0.201
(66,900.00%)
3.02k
VIVEViveve Medical Inc (CE)
$ 0.0003
(29,900.00%)
17.25k
CCTLCoin Citadel (PK)
$ 0.0002
(19,900.00%)
239.97k
TBRDFThunderbird Minerals Corp (PK)
$ 0.0161
(16,000.00%)
4.35k
ESSIEco Science Solutions Inc (PK)
$ 0.000001
(-99.80%)
500
MCNOMucinno Holding Inc (CE)
$ 0.000001
(-99.67%)
50k
NNFCNanoforce Inc (CE)
$ 0.000001
(-99.50%)
200
NMRDNemaura Medical Inc (CE)
$ 0.000001
(-99.50%)
1.2k
BLSPBlue Sphere Corporation (CE)
$ 0.000001
(-99.00%)
1.16M
HMBLHUMBL Inc (PK)
$ 0.0015
(50.00%)
1.14B
TSOITherapeutic Solutions International Inc (PK)
$ 0.0003
(-25.00%)
327.34M
NSAVNet Savings Link Inc (PK)
$ 0.0005
(-9.09%)
209.23M
MJLBUltrack Systems Inc (PK)
$ 0.00025
(25.00%)
206.64M
PDPGPerformance Drink Group Inc (PK)
$ 0.0001
(-50.00%)
183.18M

BMKDF Discussion

View Posts
MERCURIAL MERCURIAL 5 years ago
I hear you. Loading :)
šŸ‘ļø0
MADDSTACKER MADDSTACKER 5 years ago
Covid and lung cancer screening this going to dollars imho ...
šŸ‘ļø0
MADDSTACKER MADDSTACKER 5 years ago
Iā€™m so alone .. can anyone hear me .. bawhahahaha
šŸ‘ļø0
MADDSTACKER MADDSTACKER 5 years ago
Covid test kits , in talks with government ,, 2 weeks expect a roll out ....
šŸ‘ļø0
STOCKPICKER4LIFE STOCKPICKER4LIFE 8 years ago
šŸ‘ļø0
ronpopeil ronpopeil 8 years ago
Does anyone follow this company anymore?
šŸ‘ļø0
Bing420 Bing420 8 years ago
Soooo...any reason for the tanking in the last day?
šŸ‘ļø0
MichaelVest MichaelVest 8 years ago
BioMark raw data collection complete on 200 patient trial. Data will be reviewed then compiled into a report. Trial met both Health Canada and U.S. FDA standards.

Complete article below:

Data Collection
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Expect commercializing of BioMark's early detection red alert technology. Looking like 2016 will be a big year for BioMark!!!
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark receives approval from Health Canada and the Ethics Review Board for their lung cancer protocol, and will now start pilot study at CancerCare Manitoba in April.

Full article here: Lung Cancer Protocol
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Great Video BioMark Cancer Survivorship Program

Cancer Survivorship Program
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
A good article regarding BioMark

A Good Choice For MMJ and Biotech Market Opportunity
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark Announces Progress

[url][/url][tag]Progress with Assayhttp://www.biomarkdiagnostics.com/investor-relations/investment-highlights/news-releases/[/tag]
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Quest for Game Changing Lung Cancer Diagnostic Assay Video

šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark expects to begin study of its' assay in 4th quarter of 2015

Begin assay study in 4th quarter
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark receives clearance from Health Canada to commence clinical trial of their assay.

Health Canada clearance
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Interim financial report June 2015

Fin. report
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Dr. Thomas Malcolm to head U.S. operations. Brings experience to U.S. strategy.

Ph.D in molecular biology and biochemistry, and a post doctoral fellow for both Mount Sinai School of Medicine and Memorial Sloan Kettering Cancer Center.
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark lays out plan for U.S.


Going to be based in Maryland, appointed head of U.S. operations, planning on gaining approval from Health Canada in 2016, then FDA approval to follow.

U.S. Strategy
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
BioMark is four weeks out with data on their assay cancer test. Look to be meeting all requirements for FDA.

Press release here
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Two patent applications for BioMark below:

Monoclonal Antibody

and

Method for Assaying
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
Company currently holds patent for their tech. Patent number 6811967 Link below for full patent information:

Full patent info
šŸ‘ļø0
MichaelVest MichaelVest 9 years ago
From Nov. 2014 but good information on what the company is trying to do.

BioMark Diagnostics Info
šŸ‘ļø0
GoBison GoBison 10 years ago
Anyone trading this yet?
šŸ‘ļø0
jupp jupp 10 years ago
BioMark Announces Grant Funded Partnership With TMIC

www.fscwire.com/newsrelease/biomark-announces-grant-funded-partnership-tmic

BioMark Brings New Life to Cancer Detection Technology

www.biomarkdiagnostics.com/biomark-brings-new-life-to-cancer-detection-technology/

BioMark Announces Private Placement

www.fscwire.com/newsrelease/biomark-announces-private-placement
šŸ‘ļø0